Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2399.TW Stock Summary
In the News
2399.TW Financial details
Company Rating
Buy
Market Cap
4.31B
Income
33.56M
Revenue
2.28B
Book val./share
12.35
Cash/share
6.2
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
129.02
Forward P/E
-
PEG
-14.23
P/S
1.82
P/B
1.89
P/C
3.76
P/FCF
768.9
Quick Ratio
3.13
Current Ratio
5.11
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-96.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-5.96%
Revenue Q/Q
-21.64%
EPS Q/Q
-33.33%
-
-
-
-
SMA20
-
SMA50
-7.69%
SMA100
60%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
-
Gross Margin
8%
Oper. Margin
-
Profit Margin
1%
Payout
-
Shs Outstand
178.1M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
11.15-28.6
52W High
-16.79%
52W Low
+111.82%
RSI
48
Rel Volume
0.17
Avg Volume
6.87M
Volume
1.17M
Perf Week
-3.72%
Perf Month
2.87%
Perf Quarter
47%
Perf Half Y
39.52%
-
-
-
-
Beta
0.928856
-
-
Volatility
0.36%, 0.62%
Prev Close
-1.06%
Price
23.3
Change
-2.92%
2399.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 17.07 | 12.8 | 11.82 | 15.58 | 12.56 | |
Net income per share | -1.37 | 0.26 | 0.8 | 2.03 | 0.07 | |
Operating cash flow per share | -0.48 | 1.84 | -0.52 | 0.51 | -0.45 | |
Free cash flow per share | -1.06 | 1.69 | -0.54 | 0.5 | -0.47 | |
Cash per share | 4.73 | 6.47 | 8.43 | 8.75 | 6.76 | |
Book value per share | 11.17 | 11.23 | 12.07 | 13.65 | 12.62 | |
Tangible book value per share | 12.82 | 12.93 | 12.07 | 13.65 | 12.62 | |
Share holders equity per share | 11.17 | 11.23 | 12.07 | 13.65 | 12.62 | |
Interest debt per share | 0.57 | 0.59 | 0.03 | 0.02 | 0.04 | |
Market cap | 1.72B | 2.16B | 3.07B | 4.38B | 2.37B | |
Enterprise value | 1.23B | 1.5B | 2.47B | 3.73B | 1.63B | |
P/E ratio | -7.07 | 46.98 | 21.53 | 12.11 | 184.32 | |
Price to sales ratio | 0.57 | 0.95 | 1.46 | 1.58 | 1.06 | |
POCF ratio | -20.33 | 6.58 | -33.04 | 47.87 | -29.33 | |
PFCF ratio | -9.12 | 7.18 | -32.13 | 49.11 | -28.59 | |
P/B Ratio | 0.86 | 1.08 | 1.43 | 1.8 | 1.05 | |
PTB ratio | 0.86 | 1.08 | 1.43 | 1.8 | 1.05 | |
EV to sales | 0.41 | 0.66 | 1.18 | 1.34 | 0.73 | |
Enterprise value over EBITDA | -11.23 | 12.96 | 12.38 | 9.56 | 67.34 | |
EV to operating cash flow | -14.58 | 4.59 | -26.6 | 40.78 | -20.15 | |
EV to free cash flow | -6.55 | 5.01 | -25.87 | 41.83 | -19.64 | |
Earnings yield | -0.14 | 0.02 | 0.05 | 0.08 | 0.01 | |
Free cash flow yield | -0.11 | 0.14 | -0.03 | 0.02 | -0.03 | |
Debt to equity | 0.05 | 0.05 | 0 | 0 | 0 | |
Debt to assets | 0.03 | 0.03 | 0 | 0 | 0 | |
Net debt to EBITDA | 4.43 | -5.62 | -2.99 | -1.66 | -30.68 | |
Current ratio | 3 | 2.7 | 3.78 | 3.3 | 4.28 | |
Interest coverage | -97.98 | 47.48 | 454.6 | 7.64K | 140.24 | |
Income quality | 0.42 | 4.94 | -0.48 | 0.22 | -4.98 | |
Dividend Yield | 0.08 | 0 | 0 | 0.02 | 0.09 | |
Payout ratio | -0.59 | 0 | 0 | 0.2 | 16.63 | |
Sales general and administrative to revenue | 0.04 | 0.06 | 0.04 | 0.03 | 0.02 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | |
Intangibles to total assets | 0.06 | 0.05 | 0.39 | 0.34 | 0.1 | |
Capex to operating cash flow | 1.23 | -0.08 | 0.03 | -0.03 | 0.03 | |
Capex to revenue | -0.03 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -1.17 | -0.69 | -0.15 | -0.29 | -0.32 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 18.53 | 8.07 | 14.75 | 24.98 | 4.53 | |
ROIC | -0.03 | 0.03 | 0.07 | 0.14 | 0.01 | |
Return on tangible assets | -0.09 | 0.02 | 0.08 | 0.17 | 0.01 | |
Graham Net | 4.16 | 4.86 | 7.34 | 7.42 | 6.69 | |
Working capital | 1.35B | 1.3B | 1.73B | 1.91B | 1.72B | |
Tangible asset value | 2.11B | 2.13B | 1.05B | 1.33B | 1.96B | |
Net current asset value | 1.27B | 1.26B | 1.7B | 1.88B | 1.68B | |
Invested capital | 0.05 | 0.05 | 0 | 0 | 0 | |
Average receivables | 495.65M | 358.56M | 286.51M | 179.53M | 144.13M | |
Average payables | 536.4M | 404.7M | 438.43M | 479.32M | 434.19M | |
Average inventory | 848.98M | 632.89M | 559.47M | 820.97M | 961.49M | |
Days sales outstanding | 41.82 | 59.05 | 35.41 | 20.37 | 21.77 | |
Days payables outstanding | 48.55 | 79.98 | 85.45 | 85.04 | 63.64 | |
Days of inventory on hand | 101.94 | 89.72 | 122.52 | 165.21 | 167.39 | |
Receivables turnover | 8.73 | 6.18 | 10.31 | 17.92 | 16.77 | |
Payables turnover | 7.52 | 4.56 | 4.27 | 4.29 | 5.74 | |
Inventory turnover | 3.58 | 4.07 | 2.98 | 2.21 | 2.18 | |
ROE | -0.12 | 0.02 | 0.07 | 0.15 | 0.01 | |
Capex per share | -0.58 | -0.15 | -0.01 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 2.86 | 3.09 | 2.85 | 3.95 | 2.91 | |
Net income per share | -0.08 | 0.18 | -0.24 | 0.15 | 0.1 | |
Operating cash flow per share | -0.68 | 0.24 | 0.24 | -0.29 | -0.15 | |
Free cash flow per share | -0.68 | 0.24 | 0.23 | -0.29 | -0.15 | |
Cash per share | 7.67 | 6.63 | 6.76 | 6.6 | 6.2 | |
Book value per share | 12.98 | 12.96 | 12.62 | 13 | 12.35 | |
Tangible book value per share | 12.98 | 12.96 | 12.62 | 13 | 12.35 | |
Share holders equity per share | 12.98 | 12.96 | 12.62 | 13 | 12.35 | |
Interest debt per share | 0.02 | 0.01 | 0.04 | 0.03 | 0.03 | |
Market cap | 2.55B | 2.16B | 2.37B | 2.79B | 4.31B | |
Enterprise value | 1.9B | 1.55B | 1.63B | 2.11B | 3.7B | |
P/E ratio | -46.25 | 17.01 | -13.77 | 26.58 | 58 | |
Price to sales ratio | 5.18 | 3.96 | 4.67 | 4.04 | 7.97 | |
POCF ratio | -21.87 | 50.38 | 56.2 | -55.42 | -157.52 | |
PFCF ratio | -21.76 | 51.07 | 57.45 | -55.42 | -154.99 | |
P/B Ratio | 1.14 | 0.95 | 1.05 | 1.23 | 1.88 | |
PTB ratio | 1.14 | 0.95 | 1.05 | 1.23 | 1.88 | |
EV to sales | 3.85 | 2.84 | 3.21 | 3.06 | 6.84 | |
Enterprise value over EBITDA | -1.63K | 111.62 | -38.36 | 72.02 | 481.12 | |
EV to operating cash flow | -16.26 | 36.17 | 38.61 | -41.99 | -135.13 | |
EV to free cash flow | -16.18 | 36.66 | 39.46 | -41.99 | -132.95 | |
Earnings yield | -0.01 | 0.01 | -0.02 | 0.01 | 0 | |
Free cash flow yield | -0.05 | 0.02 | 0.02 | -0.02 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 563.54 | -43.85 | 17.48 | -23.03 | -79.73 | |
Current ratio | 3.21 | 4.7 | 4.28 | 4.27 | 5.11 | |
Interest coverage | -492.4 | 2.56K | -410.53 | 1.03K | 73.67 | |
Income quality | 44.95 | 3.42 | -0.92 | -1.81 | -4.93 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
Research and developement to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0 | 0 | 0.1 | 0.09 | 0.26 | |
Capex to operating cash flow | 0 | -0.01 | -0.02 | 0 | 0.02 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.44 | -0.53 | -0.33 | 0 | -0.28 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.83 | 7.24 | 8.28 | 6.62 | 5.27 | |
ROIC | -0.01 | 0.01 | -0.02 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0.01 | -0.02 | 0.01 | 0.01 | |
Graham Net | 6.6 | 6.99 | 6.69 | 6.77 | 6.68 | |
Working capital | 1.73B | 1.77B | 1.72B | 1.72B | 1.75B | |
Tangible asset value | 2.24B | 2.29B | 1.96B | 2.01B | 1.56B | |
Net current asset value | 1.69B | 1.73B | 1.68B | 1.69B | 1.71B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 189.96M | 186.58M | 161.51M | 170.34M | 192.19M | |
Average payables | 358.08M | 255.53M | 293.86M | 350.91M | 318.22M | |
Average inventory | 1.01B | 931.44M | 882.99M | 883.13M | 849.27M | |
Days sales outstanding | 33.53 | 31.28 | 23.66 | 27.03 | 29.47 | |
Days payables outstanding | 57.78 | 43.66 | 64.46 | 51.79 | 50.27 | |
Days of inventory on hand | 216.7 | 154.13 | 169.55 | 124.73 | 151.09 | |
Receivables turnover | 2.68 | 2.88 | 3.8 | 3.33 | 3.05 | |
Payables turnover | 1.56 | 2.06 | 1.4 | 1.74 | 1.79 | |
Inventory turnover | 0.42 | 0.58 | 0.53 | 0.72 | 0.6 | |
ROE | -0.01 | 0.01 | -0.02 | 0.01 | 0.01 | |
Capex per share | 0 | 0 | -0.01 | 0 | 0 |
2399.TW Frequently Asked Questions
What is Biostar Microtech International Corp. stock symbol ?
Biostar Microtech International Corp. is a TW stock and trading under the symbol 2399.TW
What is Biostar Microtech International Corp. stock quote today ?
Biostar Microtech International Corp. stock price is $23.3 today.
Is Biostar Microtech International Corp. stock public?
Yes, Biostar Microtech International Corp. is a publicly traded company.